GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Green Cross Health Ltd (NZSE:GXH) » Definitions » Research & Development

Green Cross Health (NZSE:GXH) Research & Development : NZ$0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Green Cross Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Green Cross Health's Research & Development for the six months ended in Sep. 2024 was NZ$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was NZ$0.0 Mil.


Green Cross Health Research & Development Historical Data

The historical data trend for Green Cross Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Cross Health Research & Development Chart

Green Cross Health Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Green Cross Health Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Green Cross Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Cross Health  (NZSE:GXH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Green Cross Health Research & Development Related Terms

Thank you for viewing the detailed overview of Green Cross Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Cross Health Business Description

Traded in Other Exchanges
N/A
Address
602 Great South Road, Ellerslie, Ground Floor, Building B, Millennium Centre, Auckland, NTL, NZL, 1051
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services, Medical services. The majority of the revenue is generated from the Pharmacy services segment. Its pharmacy services segment includes operations like providing pharmacy services through consolidated stores, equity-accounted investments, and franchise stores under the Unichem and Life Pharmacy brands. The medical service segment provides complete family healthcare services through general practitioners, accidents, and medical centers, with many operating under The Doctors Brand. Its community health segment provides services directly to the community to support independent living.

Green Cross Health Headlines

No Headlines